Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Refining the continuum of CFTR-associated disorders in the era of newborn screening.

Levy H, Nugent M, Schneck K, Stachiw-Hietpas D, Laxova A, Lakser O, Rock M, Dahmer MK, Biller J, Nasr SZ, Baker M, McColley SA, Simpson P, Farrell PM.

Clin Genet. 2016 May;89(5):539-49. doi: 10.1111/cge.12711. Epub 2016 Jan 20.

2.

Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

Sanders DB, Li Z, Laxova A, Rock MJ, Levy H, Collins J, Ferec C, Farrell PM.

Ann Am Thorac Soc. 2014 Jan;11(1):63-72. doi: 10.1513/AnnalsATS.201309-303OC.

3.

Long-term follow-up of cystic fibrosis newborn screening: psychosocial functioning of adolescents and young adults.

Tluczek A, Laxova A, Grieve A, Heun A, Brown RL, Rock MJ, Gershan WM, Farrell PM.

J Cyst Fibros. 2014 Mar;13(2):227-34. doi: 10.1016/j.jcf.2013.10.001. Epub 2013 Oct 21.

4.

Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health.

Tluczek A, Becker T, Grieve A, Laxova A, Rock MJ, Gershan WM, Green CG, Farrell PM.

J Dev Behav Pediatr. 2013 May;34(4):252-61. doi: 10.1097/DBP.0b013e3182905646.

5.

Nutritional status is associated with health-related quality of life in children with cystic fibrosis aged 9-19 years.

Shoff SM, Tluczek A, Laxova A, Farrell PM, Lai HJ.

J Cyst Fibros. 2013 Dec;12(6):746-53. doi: 10.1016/j.jcf.2013.01.006. Epub 2013 Feb 12.

6.

Associations between academic achievement and psychosocial variables in adolescents with cystic fibrosis.

Grieve AJ, Tluczek A, Racine-Gilles CN, Laxova A, Albers CA, Farrell PM.

J Sch Health. 2011 Nov;81(11):713-20. doi: 10.1111/j.1746-1561.2011.00648.x.

7.

Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.

Earley MC, Laxova A, Farrell PM, Driscoll-Dunn R, Cordovado S, Mogayzel PJ Jr, Konstan MW, Hannon WH.

Clin Chim Acta. 2011 Jul 15;412(15-16):1376-81. doi: 10.1016/j.cca.2011.04.011. Epub 2011 Apr 14.

8.

Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis.

Tluczek A, Becker T, Laxova A, Grieve A, Gilles CNR, Rock MJ, Gershan WM, Green CG, Farrell PM.

Chest. 2011 Jul;140(1):170-177. doi: 10.1378/chest.10-1504. Epub 2010 Nov 24.

9.

Pulmonary outcome differences in U.S. and French cystic fibrosis cohorts diagnosed through newborn screening.

Walsh AC, Rault G, Li Z, Scotet V, Duguépéroux I, Férec C, Roussey M, Laxova A, Farrell PM; participating CF centres of Brittany, France.

J Cyst Fibros. 2010 Jan;9(1):44-50. doi: 10.1016/j.jcf.2009.10.004. Epub 2009 Nov 18.

10.

Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis.

Farrell PM, Collins J, Broderick LS, Rock MJ, Li Z, Kosorok MR, Laxova A, Gershan WM, Brody AS.

Radiology. 2009 Aug;252(2):534-43. doi: 10.1148/radiol.2522081882.

11.

Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis.

Rao AR, Laxova A, Farrell PM, Barbieri JT.

J Clin Microbiol. 2009 Aug;47(8):2483-8. doi: 10.1128/JCM.02182-08. Epub 2009 Jun 24.

12.

Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen.

Kloosterboer M, Hoffman G, Rock M, Gershan W, Laxova A, Li Z, Farrell PM.

Pediatrics. 2009 Feb;123(2):e338-46. doi: 10.1542/peds.2008-1681.

PMID:
19171585
13.

Potential threats to the effective communication of genetic risk information: the case of cystic fibrosis.

Dillard JP, Shen L, Laxova A, Farrell P.

Health Commun. 2008;23(3):234-44. doi: 10.1080/10410230802055356.

PMID:
18569052
14.

Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.

Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM.

J Thorac Imaging. 2006 Mar;21(1):14-21.

PMID:
16538150
15.

Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

Braun AT, Farrell PM, Ferec C, Audrezet MP, Laxova A, Li Z, Kosorok MR, Rosenberg MA, Gershan WM.

J Cyst Fibros. 2006 Jan;5(1):33-41. Epub 2005 Nov 4.

16.

Quality of life of children with cystic fibrosis.

Koscik RL, Douglas JA, Zaremba K, Rock MJ, Splaingard ML, Laxova A, Farrell PM.

J Pediatr. 2005 Sep;147(3 Suppl):S64-8.

PMID:
16202786
17.

Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.

Koscik RL, Lai HJ, Laxova A, Zaremba KM, Kosorok MR, Douglas JA, Rock MJ, Splaingard ML, Farrell PM.

J Pediatr. 2005 Sep;147(3 Suppl):S51-6.

PMID:
16202783
18.

Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

Farrell PM, Lai HJ, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Hoffman G, Laessig R, Rock MJ, Splaingard ML.

J Pediatr. 2005 Sep;147(3 Suppl):S30-6.

PMID:
16202779
19.

Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis.

Corech R, Rao A, Laxova A, Moss J, Rock MJ, Li Z, Kosorok MR, Splaingard ML, Farrell PM, Barbieri JT.

J Clin Microbiol. 2005 Aug;43(8):3956-62.

20.

Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

Li Z, Kosorok MR, Farrell PM, Laxova A, West SE, Green CG, Collins J, Rock MJ, Splaingard ML.

JAMA. 2005 Feb 2;293(5):581-8.

PMID:
15687313
21.

Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.

Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM.

Pediatr Pulmonol. 2004 Oct;38(4):277-84.

PMID:
15334503
22.

Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition.

Koscik RL, Farrell PM, Kosorok MR, Zaremba KM, Laxova A, Lai HC, Douglas JA, Rock MJ, Splaingard ML.

Pediatrics. 2004 Jun;113(6):1549-58.

PMID:
15173473
23.

An analysis of communication following newborn screening for cystic fibrosis.

Dillard JP, Carson CL, Bernard CJ, Laxova A, Farrell PM.

Health Commun. 2004;16(2):197-205.

PMID:
15090285
24.

Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis.

Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Rock MJ, Splaingard ML.

Am J Respir Crit Care Med. 2003 Nov 1;168(9):1100-8. Epub 2003 Aug 13.

PMID:
12917228
25.

Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis.

Farrell PM, Li Z, Kosorok MR, Laxova A, Green CG, Collins J, Lai HC, Makholm LM, Rock MJ, Splaingard ML.

Pediatr Pulmonol. 2003 Sep;36(3):230-40.

PMID:
12910585
26.

Delayed diagnosis of US females with cystic fibrosis.

Lai HC, Kosorok MR, Laxova A, Makholm LM, Farrell PM.

Am J Epidemiol. 2002 Jul 15;156(2):165-73.

PMID:
12117708
27.

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM.

JAMA. 2002 Jun 12;287(22):2958-67.

PMID:
12052125
28.

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM.

Pediatr Pulmonol. 2001 Oct;32(4):277-87.

PMID:
11568988
29.

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.

Ciske DJ, Haavisto A, Laxova A, Rock LZ, Farrell PM.

Pediatrics. 2001 Apr;107(4):699-705.

PMID:
11335747
30.

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, Hoffman G, Laessig RH, Splaingard ML.

Pediatrics. 2001 Jan;107(1):1-13.

PMID:
11134427
31.

Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies.

Koscik RE, Kosorok MR, Farrell PM, Collins J, Peters ME, Laxova A, Green CG, Zeng L, Rusakow LS, Hardie RC, Campbell PW, Gurney JW.

Pediatr Pulmonol. 2000 Jun;29(6):457-67.

PMID:
10821728
32.
33.

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.

Kosorok MR, Jalaluddin M, Farrell PM, Shen G, Colby CE, Laxova A, Rock MJ, Splaingard M.

Pediatr Pulmonol. 1998 Aug;26(2):81-8.

PMID:
9727757
34.

Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM, Makholm LM, Shen G, Feenan L, McCarthy C, Farrell PM.

Pediatrics. 1998 Jul;102(1 Pt 1):44-52.

PMID:
9651412
35.

Acquisition of Pseudomonas aeruginosa in children with cystic fibrosis.

Farrell PM, Shen G, Splaingard M, Colby CE, Laxova A, Kosorok MR, Rock MJ, Mischler EH.

Pediatrics. 1997 Nov;100(5):E2.

PMID:
9346996
36.

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

Farrell PM, Kosorok MR, Laxova A, Shen G, Koscik RE, Bruns WT, Splaingard M, Mischler EH.

N Engl J Med. 1997 Oct 2;337(14):963-9.

37.

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

Gregg RG, Simantel A, Farrell PM, Koscik R, Kosorok MR, Laxova A, Laessig R, Hoffman G, Hassemer D, Mischler EH, Splaingard M.

Pediatrics. 1997 Jun;99(6):819-24.

PMID:
9164776
38.

Effect of linoleic acid intake on growth of infants with cystic fibrosis.

van Egmond AW, Kosorok MR, Koscik R, Laxova A, Farrell PM.

Am J Clin Nutr. 1996 May;63(5):746-52.

PMID:
8615359
39.

Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis. Implications for neonatal screening.

Wilfond BS, Farrell PM, Laxova A, Mischler E.

Clin Pediatr (Phila). 1994 Jan;33(1):2-7.

PMID:
8156723
40.

Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.

Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH.

Am J Hum Genet. 1993 Mar;52(3):616-26.

41.

Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention.

Marcus MS, Sondel SA, Farrell PM, Laxova A, Carey PM, Langhough R, Mischler EH.

Am J Clin Nutr. 1991 Sep;54(3):578-85.

PMID:
1877513
42.

Nutritional assessment of infants with cystic fibrosis diagnosed through screening.

Mischler EH, Marcus MS, Sondel SA, Laxova A, Carey P, Langhough R, Farrell PM.

Pediatr Pulmonol Suppl. 1991;7:56-63.

PMID:
1782132

Supplemental Content

Loading ...
Support Center